Real-life experience in switching to new extended half-life products at European haemophilia centres
The concept of replacement therapy in haemophilia is changing significantly thanks to the switch...
Read More
AIM: Pharmacologic agents with procoagulant effects and antidotes against antithrombotic drugs play an important...
Abstract BACKGROUND: In Italy, the National Register of Congenital Coagulopathies (NRCC) collects epidemiological and...
INTRODUCTION: Haemophilia A is a chronic disease requiring frequent intravenous infusions of recombinant factor...
The development of new biologic agents able to restore thrombin generation has become the...
Hemophilia is a monogenic disease with robust clinicolaboratory correlations of severity. These attributes coupled...
This study was conducted to investigate the incidence in patients with hemophilia of postoperative...
Parvovirus B19 (B19V) has been discovered in 1975. The association with a disease was...
The characterization of the human blood-associated viral community (also called blood virome) is essential...
A 2014 study by NHS Blood and Transplant indicated that over one quarter of...